SEATTLE CHILDREN'S RESEARCH INSTITUTE

Funding Organization

Awards Grant

  • A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)
  • A Prospective Study Evaluating Maternal and FetaL Outcomes in the ERa ModulatorS (MAYFLOWERS)
  • A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (the PROMISE Study)
  • A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function in Infants and Young Children (BEGIN)
  • Aquadex FlexFlow System and Renal Support using Aquadex: A Multicenter Retrospective Study
  • Baby Observational and Nutritional Study (BONUS-IP-11)
  • Characterizing CFTR Modulated Changes in Sweat Chloride & Clinical Outcomes
  • Clinical Study Site Agreement between Seattle Children’s Hospital d/b/a Seattle Children’s Research Institute and University of Alabama at Birmingham
  • Cystic Fibrosis Fibrosing Colonopathy Observational (CFFC-OB-11)
  • Early Intervention in Pulmonary Exacerbation
  • G551D Observational Study-Expanded to Additional Genotypes and Extended for Long Term Follow-Up (GOAL-e2)
  • G551D Observational Study-SEATTLE GOAL
  • Genetic Prediction for Treatment Resistance in Kawasaki Disease
  • Genetic Prediction for Treatment Resistance in Kawasaki Disease
  • Individual Project Schedule #6.0
  • Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients with Cystic Fibrosis
  • Prevalence and Significance of Staphylococcus Aureus Small–Colony Variants
  • Promoting Resilience in Stress Management (PRISM)
  • Recombinant Erythropoietin for Protection of Infant Renal Disease (REPAIReD)
  • Saline Hypertonic in Preschoolers (SHIP)
  • Testicular Effects of Modern Chemotherapy Regimens in Osteosarcoma Survivors